Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 420-423

  Heinzel, Peter A ^a   Balaram, Prabha ^b   Bernard, Hans Ulrich ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Medical College Hospital Thiruvananthapuram   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53; VIRUS ANTIGEN;

ARTICLE; BETEL NUT; COHORT ANALYSIS; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PAPILLOMA VIRUS; PRIORITY JOURNAL;

ARECA; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MOUTH NEOPLASMS; MUTATION; PLANTS, MEDICINAL; POLYMORPHISM, GENETIC;

EID: 0029851041     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<420::AID-IJC3>3.0.CO;2-2     Document Type: Article

References (21)

1. BALARAM, P., NALINAKLIMARI, K.R., ABRAHAM, E., BALAN, A., HAREENDRAN, N.K., BERNARD, H.U. and CHAN, S.Y., Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int. J. Cancer, 61, 450-454 (1995).
2. CHO, Y., GORINA, S., JEFFRY, P.D. and PAVLEVITCH, N.P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorgenic mutations. Science, 265, 346-355 (1994).
3. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W. and VOGELSTEIN, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
4. ENDERS, G.H., KOH, J., MISSERO, C., RUSTGI, A.K. and HARLOW, E., p16 inhibition of transformed and primary squamous epithelial cells. Oncogene, 12, 1239-1245 (1996).
5. FUJITA, M., INUE, M., TANIZAWA, O., IWAMOTO, S. and ENOMOTO, T., Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res., 52, 5323-5328 (1992).
6. GAO, X., CHEN, Y.Q., WU, N., GRIGNON, D.F., SAKR, W., PORTER, A.T. and HONN, K.V., Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. Oncogene, 11, 1395-1398 (1995).
7. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
8. Liu, Q., NEUHAUSEN, S., MCCLURE, M., FRYE, C., WEAVER-FELDHAUS, J., GRUIS, N.A., EDDINGTON, K., ALLALULIS-TURNER, M.J., SKOLNICK, M.H., FUJIMURA, F.K. and LAMB, A., CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene, 10, 1061-1067 (1995).
9. MAO, L., MERLO, A., BEDI, G., SHAPIRO, G.I., EDWARDS, CD., ROLLINS, B.J. and SIDRANSKY, D., A novel p16INK4A transcript. Cancer Res., 55, 2995-2997 (1995).
10. MILDE-LANGOSCH, K., ALBRECHT, K., JORAM, S., SCHLECHTE, H., GIESSING, M. and LÖNING, T., Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int. J. Cancer, 63, 639-645 (1995).
11. MOUSSES, S., ÖZCELIK, H., LEE, P.D., MALKIN, D., BULL, S.B. and ANDRULIS, J.L., Two variants of the CJP1/WAF1 gene occur together and are associated with human cancer. Hum. mol. Genet., 4, 1089-1092 (1995).
12. NAIR, M.K., GANGADHARAN, P. and PADMANABHAN, T.K., Cancer in Kerala. In: A. Gjogora and M. Ismail (eds.), Cancer prevention in developing countries, pp. 65-67, Pergamon, New York (1986).
13. NIGRO, J.M. and 15 OTHERS, Mutations in the53 gene occur in diverse human tumor types. Nature (Land), 342, 705-708 (1989).
14. SANGHVI, L.D., Cancer epidemiology: the Indian scene. J. Cancer Res. clin. Oncol., 99, 1-14 (1981).
15. SCULLY, C., Oncogenes, tumour suppressors, and viruses in oral squamous cell carcinoma. J. oral Pathol., Med., 22, 337-347 (1993).
16. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature (Land.), 366, 704-707 (1993).
17. THOMAS, S., BRENNAN, J., MARTEL, G., FRAZER, I., MONTESANO, R., SIDRANSKY, D. and HOLLSTEIN, M., Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res., 54, 3588-3593 (1994).
18. WERNESS, B.A., LEVINE, A.J. and HOWLEY, P.M., Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-79 (1990).
19. WICK, S.T., DUBAY, M.M., IMANIL, I. and BRIZUELA, L., Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16. Oncogene, 11, 2013-2019 (1995).
20. YEUDALL, W.A., CRAWFORD, R.Y., ENSLEY, J.F. and ROBBINS, K.C., MTS1/CDK41 is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis, 15, 2683-2686 (1994).
21. ZHANG, S.Y., KLEIN-SZANTO, A.J., SAUTER, E.R., SHAFARENKO, M., MITSUNAGA, S., NOBORI, T., CARSON, D.A., RIDGE, J.A. and GOOD-ROW, T.L., Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54, 5050-5053 (1994).